Charles Macfarlane

Mr. Macfarlane spent 40 years in the Procter & Gamble Company, primarily in the International Divisions, starting in consumer products marketing and later in general management.  He transferred to join the group that took P&G into the Pharmaceutical industry in 1978 and led the international start-up.  In 1985 Mr. Macfarlane led the successful acquisition of the French pharmaceutical group, Nativelle, and went on to serve as its President and Director General for six years in Paris. From this position Mr. Macfarlane also served as P&G’s pharmaceutical executive responsible for Southern Europe (86-91).  In 1991 he established the pharmaceutical Business Development role in Europe and relocated to London.  In 1996 Mr. Macfarlane assumed responsibility for all Alliance, Licensing and Acquisition activity of P&G in the expanded Health Care Global Business Unit (incorporating Pharmaceuticals, OTC medicines, Oral Care, Iams Pet Care, and Pur Water Treatment).  Mr. Macfarlane retired from P&G in September 2006.  

Since 1998 Mr. Macfarlane been a member of the Board of Directors and Executive Committee of British American Business and serves as a member of the British American Business Policy Group.  He is a member of the Institute of Directors and the Pilgrims Society. Mr. Macfarlane serves as a member of the Board of Directors of PharmaVentures and Exocyte, a Singapore based nano technology company.  He served on the Board of Healthcare Brands International, an OTC healthcare company successfully sold in 2011.


Non-Executive Director